Background illustration for clinical trials search

Paid Clinical Trials Pittsburgh

Discover 1,166 paid clinical trials in Pittsburgh, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

for
Urinary Retention Postoperative
Location: Pittsburgh PA
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Sex: Female

Age: 18+

Code: NCT04597372

Phase 2, Recruiting

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

for
Stage III Ovarian Cancer, Stage IV Ovarian Cancer,
Location: Pittsburgh PA, Jefferson Hills PA, Monroeville PA,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT05659381

Phase 3, Recruiting

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for
Large B-cell Lymphoma
Location: Pittsburgh PA, Cleveland OH, Bethesda MD, Fairfax VA,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18+

Code: NCT06500273

Phase 2, Recruiting

Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors

for
Malignant Pleural Effusion, Malignant Mesothelioma,
Location: Pittsburgh PA
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Sex: All

Age: 18 - 70+

Code: NCT07443020

Phase 1, Recruiting

Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease

for
Malignant Pleural Effusion, Malignant Mesothelioma,
Location: Pittsburgh PA
Sponsor: David Bartlett, MD

Sex: All

Age: 18 - 70+

Code: NCT07192900

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining)

for
Peritoneal (Metastatic) Cancer, Peritoneal Carcinomatosis,
Location: Pittsburgh PA
Sponsor: Patrick Wagner, MD, FACS

Sex: All

Age: 18 - 70+

Code: NCT07282834

Phase 2, Recruiting

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

for
Non-Small Cell Lung Cancer
Location: Pittsburgh PA, Cleveland OH, Columbus OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07100080

Phase 2, Phase 3, Recruiting

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

for
CLL, Chronic Lymphocytic Leukemia
Location: Pittsburgh PA, Cleveland OH, York PA, Bethesda MD,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06846671

Phase 3, Recruiting

Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors

for
Gastric Neoplasms, Esophageal Cancer, Liver Cancer,
Location: Pittsburgh PA
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Sex: All

Age: 18 - 69

Code: NCT07001592

Phase 1, Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for
Endometrial Cancer
Location: Pittsburgh PA, Columbus OH, Fairfax VA, London,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06952504

Phase 3, Recruiting

Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery

for
Oncologic Surgery, Cancer, Cancer Surgery, Hepatic Cancer,
Location: Pittsburgh PA
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Sex: All

Age: 18 - 70+

Code: NCT06731998

Recruiting

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

for
Multiple Myeloma
Location: Pittsburgh PA, Morgantown WV, Cleveland OH,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06152575

Phase 3, Recruiting

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

for
Endometrial Adenocarcinoma
Location: Pittsburgh PA, Hilliard OH, Charlottesville VA,
Sponsor: Acrivon Therapeutics

Sex: Female

Age: 18+

Code: NCT05548296

Phase 2, Recruiting

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

for
HER2-positive Advanced Solid Tumor
Location: Pittsburgh PA, Canton OH, Fairfax VA, Silver Spring MD,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05150691

Phase 1, Phase 2, Recruiting

A Study of VET3-TGI in Patients With Solid Tumors

for
Solid Tumor, Adult, Microsatellite Stable Colorectal Cancer,
Location: Pittsburgh PA, Indianapolis IN, Miami FL, Dallas TX,
Sponsor: KaliVir Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06444815

Phase 1, Recruiting

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Pittsburgh PA, Washington D.C. DC, New Brunswick NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04172532

Phase 1, Phase 2, Recruiting

Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer

for
Metastatic Microsatellite Stable Colorectal Carcinoma,
Location: Pittsburgh PA, Cincinnati OH, West Chester OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06654037

Phase 1, Recruiting

Pembrolizumab/Lenvatinib With and Without Healthy Donor FMT (hdFMT) in Relapsed/ Refractory (R/R) Melanoma

for
PD-1 Refractory Advanced Melanoma
Location: Pittsburgh PA
Sponsor: Diwakar Davar

Sex: All

Age: 18+

Code: NCT06030037

Phase 2, Recruiting

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer,
Location: Pittsburgh PA, Cleveland OH, Washington D.C. DC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06586515

Phase 1, Recruiting

Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

for
Carcinoma, Non-Small-Cell Lung Cancer,
Location: Pittsburgh PA, Norfolk VA, Tyler TX, Beverly Hills CA
Sponsor: Kiromic BioPharma Inc.

Sex: All

Age: 18+

Code: NCT06069570

Phase 1, Recruiting